These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7019106)

  • 1. Characterization of the effects of asparaginase from Escherichia coli and a glutaminase-free asparaginase from Vibrio succinogenes on specific ell-mediated cytotoxicity.
    Durden DL; Distasio JA
    Int J Cancer; 1981 Jan; 27(1):59-65. PubMed ID: 7019106
    [No Abstract]   [Full Text] [Related]  

  • 2. Glutaminase-free asparaginase from vibrio succinogenes: an antilymphoma enzyme lacking hepatotoxicity.
    Distasio JA; Salazar AM; Nadji M; Durden DL
    Int J Cancer; 1982 Sep; 30(3):343-7. PubMed ID: 6752048
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of blastogenesis by native and polyethylene glycol-modified asparaginases from Escherichia coli and Vibrio succinogenes.
    Bendich A; Kafkewitz D; Abuchowski A; Davis FF
    Immunol Commun; 1983; 12(3):273-84. PubMed ID: 6350165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in spleen lymphoid populations associated with specific amino acid depletion during L-asparaginase treatment.
    Distasio JA; Durden DL; Paul RD; Nadji M
    Cancer Res; 1982 Jan; 42(1):252-8. PubMed ID: 7032693
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the immunosuppressive effects of asparaginases from Escherichia coli and Vibrio succinogenes.
    Durden DL; Distasio JA
    Cancer Res; 1980 Apr; 40(4):1125-9. PubMed ID: 6986981
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme-induced asparagine and glutamine depletion and immune system function.
    Kafkewitz D; Bendich A
    Am J Clin Nutr; 1983 Jun; 37(6):1025-30. PubMed ID: 6342356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological properties of an asparaginase-glutaminase preparation from Pseudomonas fluorescens in cell cultures].
    Kondrat'eva NA; Dobrynin IaV; Merkulov MF
    Antibiotiki; 1978 Feb; 23(2):122-5. PubMed ID: 415658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice.
    Bendich A; Kafkewitz D; Abuchowski A; Davis FF
    Clin Exp Immunol; 1982 Apr; 48(1):273-8. PubMed ID: 7044632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaminase free l-asparaginase from Vibrio cholerae: Heterologous expression, purification and biochemical characterization.
    Radha R; Arumugam N; Gummadi SN
    Int J Biol Macromol; 2018 May; 111():129-138. PubMed ID: 29307802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the glutaminase activity of E. coli asparaginase in tissue culture.
    Oerkermann H; Hirschmann WD; Gross R
    Recent Results Cancer Res; 1970; 33():125-30. PubMed ID: 4949157
    [No Abstract]   [Full Text] [Related]  

  • 11. Antilymphoma activity of a glutaminase-free L-asparaginase of microbial origin.
    Distasio JA; Niederman RA; Kafkewitz D
    Proc Soc Exp Biol Med; 1977 Sep; 155(4):528-31. PubMed ID: 331343
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
    Holcenberg JS; Tang E; Dolowy WC
    Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of L-asparaginase on fibrinogen and fibrin clot (current data on the tumor-inhibiting mechanism of L-asparaginase)].
    Benkö S; Laki K
    Orv Hetil; 1969 Sep; 110(36):2083-7. PubMed ID: 4900425
    [No Abstract]   [Full Text] [Related]  

  • 14. The inhibition of lymphocyte mitogenesis by asparaginase: a still unexplained phenomenon.
    Kafkewitz D; Bendich A
    Experientia; 1984 Nov; 40(11):1173-7. PubMed ID: 6389170
    [No Abstract]   [Full Text] [Related]  

  • 15. [Microbial deaminases as immunosuppressants].
    Kozlov EA; Tsvetkova TA
    Vestn Akad Med Nauk SSSR; 1984; (8):80-2. PubMed ID: 6437096
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary crystal structure of Acinetobacter glutaminasificans glutaminase-asparaginase.
    Ammon HL; Weber IT; Wlodawer A; Harrison RW; Gilliland GL; Murphy KC; Sjölin L; Roberts J
    J Biol Chem; 1988 Jan; 263(1):150-6. PubMed ID: 3275637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes.
    Distasio JA; Niederman RA; Kafkewitz D; Goodman D
    J Biol Chem; 1976 Nov; 251(22):6929-33. PubMed ID: 11211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase.
    Wu MC; Arimura GK; Yunis AA
    Int J Cancer; 1978 Dec; 22(6):728-33. PubMed ID: 363626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary crystallographic study of an L-asparaginase from Vibrio succinogenes.
    Ammon HL; Murphy KC; Chandrasekhar K; Wlodawer A
    J Mol Biol; 1985 Jul; 184(1):179-81. PubMed ID: 4032477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacologic properties of L-asparaginase bonded to dacron vascular prostheses.
    Cooney DA; Weetall HH; Long E
    Biochem Pharmacol; 1975 Feb; 24(4):503-15. PubMed ID: 234240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.